Abstract A new quinoline antibiotic, aurachin RE, was isolated and identified from a culture broth of Rhodococcus erythropolis JCM 6824. The aurachin RE structure was determined based on NMR and mass spectrometric analysis. The structure is similar to that of aurachin C antibiotics that have been identified from Stigmatella aurantiaca. Compared to aurachin C, however, aurachin RE exhibits a wide and strong antimicrobial spectrum against both high-and low-GC Gram-positive bacteria.
RE [1a; IUPAC name: 1-hydroxy-2-methyl-3-(3,7,11-trimethyldodeca-9-hydroxy-2,6,10-trienyl)quinolin-4-one]. In this paper, we report on the isolation, structure elucidation, and biological properties of this compound.
R. erythropolis JCM 6824 was cultured in W-minimal medium [2] supplemented with succinate (0.2%, w/v), sucrose (0.2%, w/v), and casamino acids (0.2%, w/v). Stock seed cultures (10 6 cfu/ml) were maintained at Ϫ80°C in 10% glycerol. A 600-m l aliquot of stock seed was transferred into each of six 2-liters baffled Erlenmeyer flasks containing 600 ml of the culture medium. The fermentation was carried out on a rotary shaker at 28°C for 28 hours with agitation of 120 rpm.
The fermentation broth (3.6 liters) was centrifuged and any residual cells in the supernatant were removed by membrane filtration (0.2-m m pore size). The filtered supernatant was applied to a C18 cartridge column (SepPak ® Vac 35 cc; Waters, Milford, MA), and the column was sequentially washed with 100 ml of 20% EtOH and 30 ml of 50% EtOH. The sample was eluted with 20 ml of EtOH and then evaporated to dryness. The residue was J. Antibiot. 61(11): 680-682, 2008
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Wataru Kitagawa, Tomohiro Tamura dissolved in 1 ml of EtOH, and this solution was used for purification. The sample was subjected to reversed-phase HPLC [column: TSKgel ODS-80Ts, 4.6 mm I.D.ϫ15 cm (TOSOH, Tokyo, Japan); mobile phase: 65ϳ75% MeOH (0ϳ8 minutes) and 90% MeOH (8ϳ12 minutes); flow rate: 1.0 ml/minute; monitor wavelength: 220ϳ600 nm] [1] . A single peak that retained antibiotic activity and eluted at a retention time of 10.6 minutes, was reproducibly collected. This process yielded 0.5 mg of pure aurachin RE (1a) from the original 3.6-liters culture.
The appearance of the purified compound 1a is graybrown, and it is soluble in EtOH, MeOH, CH 3 CN, EtOAc, and DMSO, and moderately soluble in water. The molecular formula of 1a was determined to be C 25 H 33 Table 1 . The 1 H-NMR spectrum and HSQC analysis indicated the presence of 15 methyl protons, eight methylene protons, and eight methine protons, the latter of which included three olefinic protons, and four aromatic protons. The 13 C-NMR spectrum indicated the presence of 25 carbon atoms, which were assigned to five methyls, four methylenes, eight methines, and eight quaternary carbons using DEPT spectrum. DQF COSY and HMBC experiments confirmed the partial structures of 1a. As a result, the whole structure of 1a was determined as shown in Fig. 1 .
The structure of compound 1a is highly similar to that of the antibiotic aurachin C (1b), which was isolated from the Gram-negative myxobacterium, Stigmatella aurantiaca Sg a15 [3] . The sole difference between the two compounds is the presence of a hydroxyl group on the hydrocarbon chain (position C-9ЈϽ substituted) in compound 1a. The antimicrobial spectrum of compound 1a was tested by an agar diffusion assay using 10 m g of compound (Table 2) . Compound 1a exhibit wide and strong antibiotic activity against Gram-positive bacteria. Compound 1b has also been reported to exhibited antibiotic activity against Grampositive bacteria; however, in comparison, compound 1a appeared to possess considerably stronger activity. For example, 10 m g of 1a produced large growth inhibition zones against Nocardia sp. and Streptomyces sp. (Table 2) , whereas 40 mg of 1b exhibited only trace antibiotic activity against these species according to the literature [3] . In addition, compound 1a exhibited activity against the Gramnegative bacteria, Sinorhizobium sp. and Deinococcus sp. Though several aurachin analogs have previously been isolated and synthesized [3, 4] , no hydroxylated analogs (on the hydrocarbon chain) have been reported and tested. The hydroxyl group might increase the solubility of the compound in the aqueous phase and may also increase its ability to permeate bacterial cell walls. Thus, introducing a hydroxyl group might be a key factor in improving the activities of these compounds. The MIC values of compound 1a against various organisms were also examined and the determined values are listed in Table 3 . This study again demonstrated that this antibiotic is highly active against Gram-positive bacteria, particularly against the Actinobacteria. Compound 1b has been reported to exhibited MIC values of 0.2 m g/ml and 0.8 m g/ml against Arthrobacter sp., and Corynebacterium sp., respectively [3] . In contrast, compound 1a exhibited a minimum MIC value of 0.01 m g/ml against Arthrobacter sp., Corynebacterium sp., and Nocardia sp. Recently, biosynthetic genes for aurachins (auaAϳE) have been isolated and published [5] . Preliminary PCR screening for these genes in R. erythropolis JCM 6824 gave no amplified products (data not shown). These results indicated that this Rhodococcus strain does not contain aua-type biosynthetic genes or biosynthetic genes similar to those that have been isolated from Stigmatella. Although to date, two antibiotics have been isolated from the genus Rhodococcus [6ϳ8], the biosynthetic genes for these compounds have not been identified. 
